Chobanian AV,Bakris GL,Black HR,Cushman WC,Green LA,Izzo Jr JL,Jones DW,Materson BJ,Oparil S,Wright Jr JT,Roccella EJ . .The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. 2003 May, 289(19) : 2560-71.
Mobine HR,Baker AB,Wang L,Wakimoto H,Jacobsen KC,Seidman CE,Seidman JG,Edelman ER . .Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors. 2009 Mar, 1(2) : 121-8.
Bhandari SV,Bothara KG,Patil AA,Chitre TS,Sarkate AP,Gore ST,Dangre SC,Khachane CV . .Design, synthesis, and pharmacological screening of novel antihypertensive agents using a hybrid approach. 2009 Jan, 1(1) : 390-400.
Bertram G Katzung,Ka. Basic G Katzung .2003 .clinical pharmacology. EGC, (6) : 166-171.
Christiaans JA,Timmerman H . .Cardiovascular hybrid drugs: a combination of more than one pharmacological property in one single molecule. European journal of pharmaceutical sciences. 1996 Jan, 1(1) : 1-22.
Huang YC,Wu BN,Yeh JL,Chen SJ,Liang JC,Lo YC,Chen J. . .A new aspect of view in synthesizing new type β-adrenoceptor blockers with ancillary antioxidant activities. 2001 Jul, 1(7) : 1739-46.
Liang JC,Yeh JL,Wang CS,Liou SF,Tsai CH,Chen J. . .The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display α-/β-Adrenoceptor antagonist and long-acting antihypertensive activities. 2002 Mar, 1(3) : 719-30.
Boschi D,Cena C,Di Stilo A,Fruttero R,Gasco A . .Nicorandil analogs containing NO-donor furoxans and related furazans. 2000 Jul, 1(7) : 1727-32.
Breschi MC,Calderone V,Digiacomo M,Martelli A,Martinotti E,Minutolo F,Rapposelli S,Balsamo A . .NOsartans: a new class of pharmacodynamic hybrids as cardiovascular drugs. 2004 Nov, 4(23) : 5597-600.
Campiani G,Fiorini I,De Filippis MP,Ciani SM,Garofalo A,Nacci V,Giorgi G,Sega A,Botta M,Chiarini A,Budriesi R . .Cardiovascular characterization of pyrrolo benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers. 1996 Jul, 39(15) : 2922-38.
Mehanna AS,Kim JY . .Design, synthesis, and biological testing of thiosalicylamides as a novel class of calcium channel blockers. 2005 Jul, 1(13) : 4323-31.
Nguyen JT,Velázquez CA . .-dihydropyridines containing a diazen-1-ium-1, 2- diolate nitric oxide donor moiety to study calcium channel antagonist structure-activity relationships and nitric oxide release. 2005 Mar, 1(5) : 1725-38.
Perez M,Pauwels PJ,Pallard-Sigogneau I,Fourrier C,Chopin P,Palmier C,Colovray V,Halazy S. Design . .and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. 1998 Dec, 1(23) : 3423-8.
Natale NR,Rogers ME,Staples R,Triggle DJ,Rutledge A,Relationships A . .. 1999 Aug, 42(16) : 3087-93.
Yagupolskii LM,Antepohl W,Artunc F,Handrock R,Klebanov BM,Maletina II,Marxen B,Petko KI,Quast U,Vogt A,Weiss C A . .Vasorelaxation by new hybrid compounds containing dihydropyridine and pinacidil-like moieties. 1999 Dec, 42(25) : 5266-71.
Siddiqui AA,Mishra R,Shaharyar M . .Synthesis, characterization and antihypertensive activity of pyridazinone derivatives. 2010 Jun, 1(6) : 2283-90.
Abadi AH,Hegazy GH,El-Zaher AA . .Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents. 2005 Oct, 13(20) : 5759-65.
Rana K,Kaur B,Kumar B . .Synthesis and anti-hypertensive activity of some dihydropyrimidines. 2004 Indian J. Chem. 43B, : 1553-1557.
Chalina EG,Chakarova L,Staneva DT . .Synthesis, antiarrhythmic and hypotensive activity of some novel 1, 3-disubstituted ureas and phenyl N-substituted carbamates. 1998 Dec, 1(12) : 985-90.
Deprez P,Heckmann B,Corbier A,Vevert JP,Fortin M,Guillaume J . .Balanced AT1 and AT2 angiotensin II antagonists. I. New orally active 5-carboxyl imidazolyl biphenyl sulfonylureas. 1995 Nov, 16(22) : 2605-10.
Dylag T.,Zygmunt M.,Maciag D.,Handzlik J.,Bednarski M.,Filipek B.,Kiec K. .2004 .Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives. Eur. J. Med. Chem, 39 : 1013-1027.
Ferrarini PL,Mori C,Primofiore G,Da Settimo A,Breschi MC,Martinotti E,Nieri PA,Ciucci MA,(Z MA . .-iminoethers of 1, 8-naphthyridine. 1990 Jul, 1(6) : 489-96.
Fisher LE,Rosenkranz RP,Clark RD,Muchowski JM,McClelland DL,Michel A,Caroon JM,Galeazzi E,Eglen R,Whiting RL,- RL . .] hexane, a potent, selective, orally active dopamine analog with hypotensive and diuretic activity. 1995 Oct, 19(20) : 2371-6.
Hanft G,Kolassa N. . .Urapidil and some analogs with hypotensive properties show high affinities for 5- hydroxytryptamine (5-HT) binding sites of the 5-HT 1A subtype and α 1-adrenoceptor binding sites. NaunynSchmiedeberg's archives of pharmacology, 336 : 597-601.
Little HJ. . .L-type calcium channel blockers: A potential novel therapeutic approach to drug dependence. 2021 Oct, 1(4) : 1298-325.
Israili ZH,Hernández-Hernández R,Valasco M. . .The future of antihypertensive treatment. 2007 Mar, 1(2) : 121-34.
Kheli S.,Leclerer G.,- G. .1995 .-dioxides on rat aorta. Bioorg. Med. Chem, 3(1) : 495-503.
Kato T,Ozaki T,Tamura K,Suzuki Y,Akima M,Ohi N. . .Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3, 5-di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones. 1998 Oct, 41(22) : 4309-16.
Smith R.,Timmermans W.,Pieter B.,A. B.,Descovery Drug .1996 .Berger's Medicinal Chemistry. , : 265-314.
Acharjee S,Bothara KG,Bhandari SV,Maity TK . .Design, synthesis and pharmacological screening of hybrid molecules as antihypertensives. Medicinal Chemistry Research, 20 : 705-13.
Visentin S,Rolando B,Di Stilo A,Fruttero R,Novara M,Carbone E,Roussel C,Vanthuyne N,Gasco A . .New 1, 4-dihydropyridines endowed with NO-donor and calcium channel agonist properties. 2004 May, 6(10) : 2688-93.
Waring WS,Webb DJ . .Is there a need for novel antihypertensive therapies Drug Discovery Today: Therapeutic Strategies. 2004 Oct, 1(2) : 143-8.
Takkar P,Singh B,Pani B,Kumar R .2023 .Design, synthesis and in silico evaluation of newer 1, 4-dihydropyridine based amlodipine bio-isosteres as promising antihypertensive agents. RSC advances, 13(48) : 34239-48.
Trott O,Olson AJ . .AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. 2010 Jan, 30(2) : 455-61.
Bowers KJ,Chow E,Xu H,Dror RO,Eastwood MP,Gregersen BA,Klepeis JL,Kolossvary I,Moraes MA,Sacerdoti FD,Salmon JK . .Scalable algorithms for molecular dynamics simulations on commodity clusters. In Proceedings of the 2006 ACM/IEEE Conference on Supercomputing 2006 Nov, 11 : 84-es.
Doherty W,Adler N,Knox A,Nolan D,McGouran J,Nikalje AP,Lokwani D,Sarkate A,Evans P . .Synthesis and evaluation of 1, 2, 3‐triazole‐containing vinyl and allyl sulfones as anti‐trypanosomal agents. 2017 Jan, 3(2017) : 175-85.
Friesner RA,Banks JL,Murphy RB,Halgren TA,Klicic JJ,Mainz DT,Repasky MP,Knoll EH,Shelley M,Perry JK,Shaw DE . .Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. 2004 Mar, 25(7) : 1739-49.
Karnik KS,Narula IS,Sarkate AP,Wakte PS . .Auto QSAR fast approach for creation and application of QSAR models through automation. 2020 May, 22(19) : 5756-62.